相似文献
1
Mucus-Activatable Shiga Toxin Genotype stx2d in Escherichia coli O157:H7.
Emerg Infect Dis. 2017 Aug;23(8):1431-1433. doi: 10.3201/eid2308.170570.
2
Shiga toxin activatable by intestinal mucus in Escherichia coli isolated from humans: predictor for a severe clinical outcome.
Clin Infect Dis. 2006 Nov 1;43(9):1160-7. doi: 10.1086/508195. Epub 2006 Oct 2.
3
Contribution and Interaction of Shiga Toxin Genes to O157:H7 Virulence.
Toxins (Basel). 2019 Oct 18;11(10):607. doi: 10.3390/toxins11100607.
4
Isolation of an Escherichia coli O157:H7 strain producing Shiga toxin 1 but not Shiga toxin 2 from a patient with hemolytic uremic syndrome in Korea.
FEMS Microbiol Lett. 1998 Sep 1;166(1):43-8. doi: 10.1111/j.1574-6968.1998.tb13181.x.
5
Strong association between shiga toxin-producing Escherichia coli O157 and virulence genes stx2 and eae as possible explanation for predominance of serogroup O157 in patients with haemolytic uraemic syndrome.
Eur J Clin Microbiol Infect Dis. 2003 Dec;22(12):726-30. doi: 10.1007/s10096-003-1025-0. Epub 2003 Nov 12.
6
Genotypic characterization of Escherichia coli O157:H7 strains that cause diarrhea and hemolytic uremic syndrome in Neuquén, Argentina.
Int J Med Microbiol. 2014 May;304(3-4):499-504. doi: 10.1016/j.ijmm.2014.02.011. Epub 2014 Mar 18.
7
Characterization and epidemiologic subtyping of Shiga toxin-producing Escherichia coli strains isolated from hemolytic uremic syndrome and diarrhea cases in Argentina.
Foodborne Pathog Dis. 2006 Spring;3(1):88-96. doi: 10.1089/fpd.2006.3.88.
8
Virulence genes, Shiga toxin subtypes, major O-serogroups, and phylogenetic background of Shiga toxin-producing Escherichia coli strains isolated from cattle in Iran.
Microb Pathog. 2017 Aug;109:274-279. doi: 10.1016/j.micpath.2017.05.041. Epub 2017 May 31.
9
Genomic analysis of shiga toxin-containing Escherichia coli O157:H7 isolated from Argentinean cattle.
PLoS One. 2021 Oct 28;16(10):e0258753. doi: 10.1371/journal.pone.0258753. eCollection 2021.
10
Multiple antibiotic resistances among Shiga toxin producing Escherichia coli O157 in feces of dairy cattle farms in Eastern Cape of South Africa.
BMC Microbiol. 2015 Oct 16;15:213. doi: 10.1186/s12866-015-0553-y.
引用本文的文献
1
Shiga toxin-producing illness in Aotearoa | New Zealand, 2016-2022: epidemiological, genomic and traditional typing analyses provide insight into a significant endemic disease while highlighting knowledge gaps.
Front Microbiol. 2025 Jul 2;16:1605469. doi: 10.3389/fmicb.2025.1605469. eCollection 2025.
2
Pathogenomes and variations in Shiga toxin production among geographically distinct clones of O113:H21.
Microb Genom. 2022 Apr;8(4). doi: 10.1099/mgen.0.000796.
3
Switching Shiga Toxin (Stx) Type from Stx2d to Stx2a but Not Stx2c Alters Virulence of Stx-Producing (STEC) Strain B2F1 in Streptomycin (Str)-Treated Mice.
Toxins (Basel). 2021 Jan 15;13(1):64. doi: 10.3390/toxins13010064.
4
Clinical and Genomic Epidemiology of Carbapenem-Nonsusceptible spp. at a Tertiary Health Care Center over 2 Decades.
J Clin Microbiol. 2020 Aug 24;58(9). doi: 10.1128/JCM.00275-20.
5
Presence of Shiga Toxin-Producing (STEC) in Fresh Beef Marketed in 13 Regions of ITALY (2017).
Microorganisms. 2018 Dec 6;6(4):126. doi: 10.3390/microorganisms6040126.
6
Evolutionary Context of Non-Sorbitol-Fermenting Shiga Toxin-Producing Escherichia coli O55:H7.
Emerg Infect Dis. 2017 Dec;23(12):1966-1973. doi: 10.3201/eid2312.170628.
本文引用的文献
1
Diversity of Shiga Toxin-Producing Escherichia coli (STEC) O26:H11 Strains Examined via stx Subtypes and Insertion Sites of Stx and EspK Bacteriophages.
Appl Environ Microbiol. 2015 Jun;81(11):3712-21. doi: 10.1128/AEM.00077-15. Epub 2015 Mar 27.
2
Development of three multiplex PCR assays targeting the 21 most clinically relevant serogroups associated with Shiga toxin-producing E. coli infection in humans.
PLoS One. 2015 Jan 28;10(1):e0117660. doi: 10.1371/journal.pone.0117660. eCollection 2015.
3
Characteristics of emerging human-pathogenic Escherichia coli O26:H11 strains isolated in France between 2010 and 2013 and carrying the stx2d gene only.
J Clin Microbiol. 2015 Feb;53(2):486-92. doi: 10.1128/JCM.02290-14. Epub 2014 Nov 26.
4
Haemolytic-uraemic syndrome with bacteraemia caused by a new hybrid Escherichia coli pathotype.
New Microbes New Infect. 2014 Jul;2(4):127-31. doi: 10.1002/nmi2.49. Epub 2014 May 27.
5
Carriage of stx2a differentiates clinical and bovine-biased strains of Escherichia coli O157.
PLoS One. 2012;7(12):e51572. doi: 10.1371/journal.pone.0051572. Epub 2012 Dec 11.
6
Multicenter evaluation of a sequence-based protocol for subtyping Shiga toxins and standardizing Stx nomenclature.
J Clin Microbiol. 2012 Sep;50(9):2951-63. doi: 10.1128/JCM.00860-12. Epub 2012 Jul 3.
7
The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli.
Clin Infect Dis. 2006 Dec 15;43(12):1587-95. doi: 10.1086/509573. Epub 2006 Nov 9.
8
Shiga toxin activatable by intestinal mucus in Escherichia coli isolated from humans: predictor for a severe clinical outcome.
Clin Infect Dis. 2006 Nov 1;43(9):1160-7. doi: 10.1086/508195. Epub 2006 Oct 2.
9
Identification of Escherichia coli flagellar types by restriction of the amplified fliC gene.
Res Microbiol. 2000 Sep;151(7):535-46. doi: 10.1016/s0923-2508(00)00223-0.
10
Activation of Shiga-like toxins by mouse and human intestinal mucus correlates with virulence of enterohemorrhagic Escherichia coli O91:H21 isolates in orally infected, streptomycin-treated mice.
Infect Immun. 1996 May;64(5):1569-76. doi: 10.1128/iai.64.5.1569-1576.1996.
Zotero 插件